Literature DB >> 2849758

Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.

C Jaxel1, K W Kohn, Y Pommier.   

Abstract

Camptothecin is an antitumor drug, which is a specific inhibitor of eukaryotic topoisomerase I. Enzyme inhibition is related to the stabilization of cleavable complexes between topoisomerase I and DNA. The genomic and DNA sequence localization of L1210 topoisomerase I-mediated DNA breaks produced by camptothecin were determined in the SV40 genome. DNA cleavage was predominantly single-stranded and localized in selective regions of the DNA. A major cleavage site was found at nucleotide 4995 on the coding strand in the early transcription region. The DNA sequence was determined at prominent cleavage sites (nucleotides 127 and 199 in the two 72 bp repeats and nucleotide 4955). A DNA consensus sequence 5'-GATG-3' was found in SV40 DNA. Cleavage occurred between the T and the G and topoisomerase I was linked to the 3'-DNA terminus at the T position. The sequence GATG is more frequent in the non transcribed strand of the early and late transcription of SV40 than in the transcribed strands. This finding is consistent with the role of topoisomerase I in transcription.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849758      PMCID: PMC339002          DOI: 10.1093/nar/16.23.11157

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

Review 1.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing.

Authors:  M D Been; J J Champoux
Journal:  J Mol Biol       Date:  1984-12-15       Impact factor: 5.469

3.  DNA structural features that lead to strand breakage by eukaryotic type-I topoisomerase.

Authors:  J J Champoux; W K McCoubrey; M D Been
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1984

4.  Contact points between a positive transcription factor and the Xenopus 5S RNA gene.

Authors:  S Sakonju; D D Brown
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

Authors:  B J Bonven; E Gocke; O Westergaard
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.

Authors:  E Kjeldsen; S Mollerup; B Thomsen; B J Bonven; L Bolund; O Westergaard
Journal:  J Mol Biol       Date:  1988-07-20       Impact factor: 5.469

7.  Altered mobility of polydeoxyribonucleotides in high resolution polyacrylamide gels due to removal of terminal phosphates.

Authors:  D P Tapper; D A Clayton
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

8.  Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome.

Authors:  G Fleischmann; G Pflugfelder; E K Steiner; K Javaherian; G C Howard; J C Wang; S C Elgin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.

Authors:  T Uemura; M Yanagida
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  17 in total

1.  Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.

Authors:  Y Pommier; G Kohlhagen; P Pourquier; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.

Authors:  Yeonee Seol; Hongliang Zhang; Keli Agama; Nicholas Lorence; Yves Pommier; Keir C Neuman
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

3.  Optimum DNA relaxation reaction conditions for calf thymus DNA-topoisomerase I are determined by specific enzyme features.

Authors:  S Coderoni; M Paparelli; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1990-11       Impact factor: 2.316

4.  Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.

Authors:  I I Gromova; V L Buchman; R A Abagyan; A V Ulyanov; I B Bronstein
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

5.  Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.

Authors:  J Schaak; P Schedl; T Shenk
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

6.  Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites.

Authors:  Y Pommier; P N Cockerill; K W Kohn; W T Garrard
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 7.  DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.

Authors:  Y Pommier
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

Authors:  S E Porter; J J Champoux
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

9.  Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.

Authors:  A Tanizawa; K W Kohn; Y Pommier
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

10.  Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.

Authors:  Smitha Antony; Paola B Arimondo; Jian-Sheng Sun; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2004-10-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.